康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688185 康希诺

交易中 03-11 13:56:21

{"stockData":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":61.12,"timestamp":1741672581000,"preClose":62.5,"halted":0,"volume":969191,"delay":0,"changeRate":-0.0221,"floatShares":114999999,"shares":247000000,"eps":-2.9102,"marketStatus":"交易中","change":-1.38,"latestTime":"03-11 13:56:21","open":61.85,"high":62.01,"low":60.97,"amount":59599700,"amplitude":0.0166,"askPrice":61.15,"askSize":2,"bidPrice":61.09,"bidSize":22,"shortable":0,"etf":0,"ttmEps":-2.9102,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1741676400000},"marketStatusCode":2,"adr":0,"adjPreClose":62.5,"symbolType":"stock_kcb","openAndCloseTimeList":[[1741656600000,1741663800000],[1741669200000,1741676400000]],"highLimit":68.75,"lowLimit":56.25,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":247449899,"isCdr":false,"pbRate":3.05,"roa":"--","roe":"--","epsLYR":-6.01,"committee":0.775,"marketValue":15124000000,"turnoverRate":0.0084,"status":1,"hkstockBrief":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":35.3,"timestamp":1741672595551,"preClose":36.35,"halted":0,"volume":664835,"delay":0,"premium":"-46.09"},"floatMarketCap":7015000000},"requestUrl":"/m/hq/s/688185/wiki","defaultTab":"wiki","newsList":[{"id":"2517492959","title":"每周股票复盘：康希诺（688185）H股和A股股本详情公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2517492959","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517492959?lang=zh_cn&edition=full","pubTime":"2025-03-08 11:18","pubTimestamp":1741403890,"startTime":"0","endTime":"0","summary":"截至2025年3月7日收盘，康希诺报收于63.09元，较上周的63.88元下跌1.24%。本周关注点公司公告汇总：康希诺提交了截至2025年2月28日的证券变动月报表，详细列出了H股和A股的法定/注册股份数目及已发行股份情况。截至2025年2月28日，2022年2月7日至2022年12月1日期间回购合计406,098股普通股A股未注销，并以库存A股持有。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030800063147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","159982","399300","BK0239"],"gpt_icon":0},{"id":"2517113108","title":"康希诺03月07日主力净流出572万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517113108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517113108?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:22","pubTimestamp":1741332151,"startTime":"0","endTime":"0","summary":"03月07日, 康希诺股价跌2.19%，报收63.09元，成交金额8051万元，换手率1.10%，振幅3.16%，量比0.87。康希诺今日主力资金净流出572万元，上一交易日主力净流入242万元。该股近5个交易日下跌1.24%，主力资金累计净流出1476万元；近20日主力资金累计净流出3219万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307164402abecbd69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307164402abecbd69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2517133791","title":"康希诺03月06日主力净流入242万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517133791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517133791?lang=zh_cn&edition=full","pubTime":"2025-03-06 15:21","pubTimestamp":1741245709,"startTime":"0","endTime":"0","summary":"03月06日, 康希诺股价涨2.95%，报收64.50元，成交金额8802万元，换手率1.19%，振幅3.48%，量比0.82。康希诺今日主力资金净流入242万元，上一交易日主力净流出257万元。该股近5个交易日下跌4.84%，主力资金累计净流出3119万元；近20日主力资金累计净流出3850万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306163445a2622071&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306163445a2622071&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2517777972","title":"康希诺生物盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517777972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517777972?lang=zh_cn&edition=full","pubTime":"2025-03-06 09:40","pubTimestamp":1741225255,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时40分，康希诺生物股票出现波动，股价大幅拉升5.00%。截至发稿，该股报37.800港元/股，成交量52.14万股，换手率0.39%，振幅3.33%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中，整体涨幅为0.93%。康希诺生物公司简介：许可项目:第三类医疗器械经营;药品生产;药品进出口;药品零售;药品批发;货物进出口;技术进出口。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094055abea71f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306094055abea71f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","06185","BK0239"],"gpt_icon":0},{"id":"2517961329","title":"康希诺副总经理朱涛：围绕公共卫生防控痛点布局管线，进一步开发国际市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2517961329","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517961329?lang=zh_cn&edition=full","pubTime":"2025-03-05 15:42","pubTimestamp":1741160546,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["NUGT","GCmain","SGCmain","GLD","DUST","518880","159831","159646","BK0239","159934","SGUmain","IAU","688185","MGCmain","GDX"],"gpt_icon":0},{"id":"2516791656","title":"全国政协委员、康希诺生物首席科学官朱涛：希望通过政策优化医药创新生态 支持医药创新成果转化","url":"https://stock-news.laohu8.com/highlight/detail?id=2516791656","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516791656?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:06","pubTimestamp":1741021575,"startTime":"0","endTime":"0","summary":"医药创新成果的转化效率，直接关系着人民的生命健康。目前，医药创新成果转化过程较为复杂，涉及科研机构、企业、监管部门等多个主体，现有的部分政策和机制一定程度上制约了成果转化的效率。为此，希望通过政策优化医药创新生态、支持医药创新成果转化，可以在审批流程上进行改进，提高疫苗等新药上市转化效率。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304010616989a3325&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304010616989a3325&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","159938","BK0239"],"gpt_icon":0},{"id":"2516868398","title":"康希诺：mRNA技术平台可应用于多类生物制品的开发，包括肿瘤领域及免疫治疗也可以是拓展方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2516868398","media":"互动易","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516868398?lang=zh_cn&edition=full","pubTime":"2025-03-03 17:09","pubTimestamp":1740992941,"startTime":"0","endTime":"0","summary":"有投资者向康希诺提问， 贵公司上海康希诺的定位是什么？疫苗+药品是公司唯一壮大的途径，上海康希诺未来是否向创新肿瘤药和创新免疫药方面发展？谢谢。公司回答表示，尊敬的投资人您好，康希诺上海子公司主要为mRNA技术等前沿技术的探索与技术积累转化而设立。mRNA技术平台可应用于多类生物制品的开发，包括肿瘤领域及免疫治疗也可以是拓展方向。现阶段公司将在做好主营业务的基础上进行延展探索。未来如有阶段性进展，将及时分享。谢谢！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303171942a25cddb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303171942a25cddb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","BK1161","06185","BK1515","688185"],"gpt_icon":0},{"id":"2516750451","title":"康希诺03月03日遭主力抛售715万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516750451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516750451?lang=zh_cn&edition=full","pubTime":"2025-03-03 15:20","pubTimestamp":1740986425,"startTime":"0","endTime":"0","summary":"03月03日, 康希诺股价跌0.41%，报收63.62元，成交金额9307万元，换手率1.26%，振幅3.44%，量比0.57。康希诺今日主力资金净流出715万元，连续4日净流出，上一交易日主力净流出2215万元。|03月03日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|N毓恬冠佳|22.87%|#|长荣股份|5.96%|#|贝瑞基因|5.64%|#|永鼎股份|4.50%|#|皇庭国际|4.37%|#|塞力医疗|4.28%|#|丰立智能|4.20%|#|深康佳Ａ|4.11%|#|云鼎科技|3.92%|#|金奥博|3.87%|康希诺所在的生物制品行业，今日主力净流出4458万元，行业排名65/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303160608abe5ae59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303160608abe5ae59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2516300833","title":"每周股票复盘：康希诺（688185）归属净利润亏损3.789亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516300833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516300833?lang=zh_cn&edition=full","pubTime":"2025-03-01 06:16","pubTimestamp":1740780974,"startTime":"0","endTime":"0","summary":"截至2025年2月28日收盘，康希诺报收于63.88元，较上周的64.21元下跌0.51%。本周，康希诺2月26日盘中最高价报68.22元。2月25日盘中最低价报62.1元。康希诺当前最新总市值158.07亿元，在生物制品板块市值排名17/50，在两市A股市值排名998/5130。本周关注点业绩披露要点：康希诺归属净利润亏损3.789亿元，同比增长74.45%业绩披露要点康希诺近日即将发布2024年年报，根据2月27日发布的业绩快报，归属净利润亏损3.789亿元，同比增长74.45%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030100010012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185"],"gpt_icon":0},{"id":"2514031112","title":"康希诺02月28日遭主力抛售2215万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514031112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514031112?lang=zh_cn&edition=full","pubTime":"2025-02-28 15:19","pubTimestamp":1740727199,"startTime":"0","endTime":"0","summary":"02月28日, 康希诺股价跌5.75%，报收63.88元，成交金额1.37亿元，换手率1.83%，振幅6.58%，量比0.86。康希诺今日主力资金净流出2215万元，连续3日净流出，上一交易日主力净流出865万元。该股近5个交易日下跌0.51%，主力资金累计净流出2903万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出3008万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228160018a2578699&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228160018a2578699&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2514923943","title":"康希诺大跌5% 业绩快报净亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2514923943","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514923943?lang=zh_cn&edition=full","pubTime":"2025-02-28 14:02","pubTimestamp":1740722525,"startTime":"0","endTime":"0","summary":"02月28日，康希诺股价大幅下跌，截至14点02分，康希诺下跌5.18%，报64.27元/股，成交1.10亿元，换手率1.45%。消息解读康希诺披露2024年度业绩快报，公司实现营业收入8.46亿元，同比增加137.01%；实现归属于母公司所有者的净亏损3.79亿元，同比亏损减少；实现归属于母公司所有者的扣除非经常性损益的净亏损4.41亿元。主营业务及业绩康希诺公司主营业务为研发、生产和商业化符合中国及国际标准的创新型疫苗企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281402219895e2b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281402219895e2b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2514690973","title":"康希诺生物盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514690973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514690973?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:53","pubTimestamp":1740707587,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘09时53分，康希诺生物股票出现波动，股价快速跳水5.08%。截至发稿，该股报39.200港元/股，成交量50.56万股，换手率0.38%，振幅5.33%。康希诺生物股票所在的生物技术行业中，整体涨幅为2.05%。公告显示，康希诺2024年实现营收8.46亿元，同比增加137.01%，净利润为亏损3.79亿元，同比缩窄了74.45%，扣非后净利润亏损为4.41亿元，同比减少了72.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095307abe00b71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228095307abe00b71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1161","BK1574","06185","688185"],"gpt_icon":0},{"id":"2514480470","title":"康希诺去年亏损收窄超7成","url":"https://stock-news.laohu8.com/highlight/detail?id=2514480470","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514480470?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:56","pubTimestamp":1740660960,"startTime":"0","endTime":"0","summary":"来源：@究竟视频微博    2月27日，康希诺发布的2024年业绩快报显示，亏损在大幅收窄。2024年，康希诺实现营业收入8.46亿元，同比增加137.01%；归属于母公司所有者的净利润亏损3.79亿元，同比亏损减少74.45%。2023年，康希诺归属于母公司所有者的净利润亏损达到14.83亿元，创下公司2020年登陆科创板上市以来年度亏损之最，主要受新冠疫苗业务拖累。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2025-02-27/doc-inemxvsi0674073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2514767758","title":"康希诺(688185.SH)2024年度净亏损3.79亿元，同比亏损减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2514767758","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514767758?lang=zh_cn&edition=full","pubTime":"2025-02-27 17:56","pubTimestamp":1740650203,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺(688185.SH)披露2024年度业绩快报，公司实现营业收入8.46亿元，同比增加137.01%;实现归属于母公司所有者的净亏损3.79亿元，同比亏损减少;实现归属于母公司所有者的扣除非经常性损益的净亏损4.41亿元。基本每股亏损1.53元。报告期内，营业总收入同比增加137.01%，变动主要系：曼海欣®作为中国市场上唯一的四价流脑结合疫苗，公司通过对其市场的精准布局推动持续放量，产品渗透率不断提升，实现销量快速增长;同时，公司经营受全球公共卫生事件的影响已经基本消除。因此，公司营业收入较去年同期大幅增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2514820540","title":"康希诺2024年度业绩快报：营收8.46亿元 同比增137.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514820540","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514820540?lang=zh_cn&edition=full","pubTime":"2025-02-27 16:47","pubTimestamp":1740646020,"startTime":"0","endTime":"0","summary":"2月27日，康希诺发布公告，2024年度业绩快报显示，公司实现营业总收入8.46亿元，同比增加137.01%。在亏损方面，归母净利润约亏损3.79亿元；扣除非经常性损益的归母净利润约亏损4.41亿元。基本每股收益为-1.53元，较上年同期的-6.01元有所改善。公告中提到，公司总资产为79.58亿元，同比减少14.6%；归属于母公司的所有者权益为49.1亿元，同比减少6.91%。2024年前三季度，康希诺实现收入5.67亿元，归母净利润-2.22亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502271654129894aca7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502271654129894aca7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","688185"],"gpt_icon":0},{"id":"2514482438","title":"康希诺：2024年实现营业收入84633.81万元，同比增加137.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514482438","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514482438?lang=zh_cn&edition=full","pubTime":"2025-02-27 16:20","pubTimestamp":1740644423,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2514274410","title":"康希诺生物盘中异动 快速拉升5.09%报39.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514274410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514274410?lang=zh_cn&edition=full","pubTime":"2025-02-26 09:49","pubTimestamp":1740534565,"startTime":"0","endTime":"0","summary":"2025年02月26日早盘09时49分，康希诺生物股票出现波动，股价急速拉升5.09%。截至发稿，该股报39.250港元/股，成交量79.56万股，换手率0.60%，振幅3.61%。资金方面，该股资金流入1757.74万港元，流出981.736万港元。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中，整体涨幅为0.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022609492596307fda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022609492596307fda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","BK0239","688185"],"gpt_icon":0},{"id":"2514803554","title":"康希诺生物持续上涨逾12% DTcP-Hib-MCV4联合疫苗获得药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2514803554","media":"新浪网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514803554?lang=zh_cn&edition=full","pubTime":"2025-02-25 11:05","pubTimestamp":1740452702,"startTime":"0","endTime":"0","summary":"康希诺生物早盘持续走高，股价上涨12.54%，现报38.60港元，成交额1.14亿港元。康希诺生物公布，公司研发的吸附无细胞百（组分）白破（“DTcP”）b型流感嗜血杆菌（结合）（“Hib”）-ACYW135群脑膜炎球菌（结合）（“MCV4”）联合疫苗（“DTcPHib-MCV4联合疫苗”）已获得中国国家药品监督管理局批准，可以开展相关临床试验。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225114208962f500a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225114208962f500a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2514805270","title":"康希诺涨5%创近2月新高 近半年1家券商买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2514805270","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514805270?lang=zh_cn&edition=full","pubTime":"2025-02-25 10:48","pubTimestamp":1740451707,"startTime":"0","endTime":"0","summary":"02月25日，康希诺股价大幅上涨，截至10点48分，康希诺上涨5.01%，报65.80元/股，创近2个月新高，成交9546万元，换手率1.30%，振幅5.90%。此外，数据统计显示，近半年内1家券商给予买入建议。资金动向截止发稿，康希诺获得主力净流入1275万元，其中超大单流入962万元，大单流入313万元。主营业务及业绩康希诺公司主营业务为研发、生产和商业化符合中国及国际标准的创新型疫苗企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022510483298919cc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022510483298919cc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2514087552","title":"康希诺生物盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514087552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514087552?lang=zh_cn&edition=full","pubTime":"2025-02-25 10:21","pubTimestamp":1740450113,"startTime":"0","endTime":"0","summary":"2025年02月25日早盘10时21分，康希诺生物股票出现异动，股价急速上涨5.10%。截至发稿，该股报36.050港元/股，成交量58.88万股，换手率0.44%，振幅7.29%。康希诺生物股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，北海康成-B、歌礼制药-B、华康生物医学涨幅较大，振幅较大的相关个股有晶泰控股-P、药明巨诺-B、腾盛博药-B，振幅分别为13.57%、11.32%、10.28%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225102153abdbabc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225102153abdbabc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185","06185"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1741672609504,"stockEarnings":[{"period":"1week","weight":-0.0176},{"period":"1month","weight":0.0166},{"period":"3month","weight":-0.0875},{"period":"6month","weight":0.5759},{"period":"1year","weight":0.1748},{"period":"ytd","weight":0.0238}],"compareEarnings":[{"period":"1week","weight":0.0148},{"period":"1month","weight":0.0189},{"period":"3month","weight":-0.0165},{"period":"6month","weight":0.2367},{"period":"1year","weight":0.1051},{"period":"ytd","weight":0.0043}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康希诺生物股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"19054人(较上一季度减少0.54%)","perCapita":"6023股","listingDate":"2020-08-13","address":"天津市东丽区经济技术开发区西区南大街185号西区生物医药园四层401-420","registeredCapital":"24744万元","survey":"　　康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司主要产品为埃博拉病毒病疫苗、脑膜炎疫苗、百白破疫苗、肺炎疫苗、结核病疫苗、带状疱疹疫苗、新冠肺炎疫苗、腺病毒疫苗、脊髓灰质炎疫苗。公司获得了“天津瞪羚企业卓越创新奖”、“中国最具成长力科技创新型医药企业”、“天津市呼吸道细菌重组及结合疫苗企业重点实验室”等多项荣誉。","listedPrice":209.71},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.5","shortVersion":"4.31.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺,688185,康希诺股票,康希诺股票老虎,康希诺股票老虎国际,康希诺行情,康希诺股票行情,康希诺股价,康希诺股市,康希诺股票价格,康希诺股票交易,康希诺股票购买,康希诺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}